09.11.2011 • News

Albemarle Executive Chairman Mark Rohr to Take Over at Celanese

Celanese Chairman and CEO David N. Weidman will be retiring in April 2012.
Celanese Chairman and CEO David N. Weidman will be retiring in April 2012.

Celanese Chairman and CEO David N. Weidman will be retiring in April 2012. The company's board of directors has appointed Mark C. Rohr as his successor. Rohr is currently the executive chairman of Albemarle's board. He will step down from that position on Feb. 1.

Weidman joined Celanese in 2000. In 2002 he was named chief operating officer and was named chief executive officer in 2004 following the company's move from Germany to the United States. Weidman led the company through its initial public offering in January 2005 and was elected chairman of the board in 2007.

Company

Celanese

Brüningstr.
Frankfurt
Germany

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read